You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Claims for Patent: 7,659,445


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,659,445
Title:Expression of plasminogen and microplasminogen in duck weed
Abstract: The present invention provides methods and compositions for the production of recombinant plasminogen, microplasminogen, and fragments thereof in a duckweed expression system. It is the novel finding of the present invention that a duckweed expression system may be used to produce high levels of plasminogen and microplasminogen. The duckweed-produced plasminogen and microplasminogen can be activated to produce a polypeptide having protease activity. Thus, the invention encompasses methods for the expression of plasminogen, microplasminogen, and fragments thereof in duckweed, duckweed plants that are transformed with expression cassettes for the expression of plasminogen, microplasminogen, and fragments thereof, and nucleic acids comprising nucleotide sequences encoding plasminogen, microplasminogen, and fragments thereof, where these nucleotide sequences are modified to enhance their expression in duckweed.
Inventor(s): Spencer; David (Chapel Hill, NC), Dickey; Lynn F. (Cary, NC), Gasdaska; John R. (Carrboro, NC), Wang; Xiaowei (Carrboro, NC), Cox; Kevin M. (Raleigh, NC), Peele; Charles G. (Apex, NC)
Assignee: Biolex Therapeutics, Inc. (Pittsboro, NC)
Application Number:11/056,621
Patent Claims:1. A method for producing high levels of stable plasminogen in duckweed, wherein said method comprises the steps of: (a) culturing a duckweed plant or duckweed plant cell or nodule, wherein said duckweed plant or duckweed plant cell or nodule is stably transformed with a nucleic acid molecule comprising a nucleotide sequence encoding plasminogen, wherein said nucleic acid molecule comprises: 1) duckweed-preferred codons in the coding sequence for said plasminogen; 2) an operably linked nucleotide sequence comprising a plant intron that is inserted upstream of the coding sequence for said plasminogen; 3) an operably linked nucleotide sequence coding for a signal peptide, said signal peptide-encoding sequence inserted between said intron and said plasminogen-encoding sequence; and 4) an operably linked nucleotide sequence comprising the translation leader sequence from the ribulose-bis-phosphate carboxylase small subunit 5B gene of Lemna gibba; and (b) collecting said stable plasminogen from said duckweed plant or duckweed plant cell or nodule.

2. The method according to claim 1, wherein the nucleotide sequence encoding plasminogen comprises between 70-100% duckweed-preferred codons.

3. The method according to claim 1, wherein said plant intron is an intron from maize alcohol dehydrogenase 1 gene.

4. The method according to claim 3, wherein said plant intron is SEQ ID NO: 1.

5. The method according to claim 1, wherein said translation leader sequence is SEQ ID NO:2.

6. The method according to claim 1, wherein said plasminogen is human plasminogen.

7. The method according to claim 6, wherein said plasminogen has at least 95% sequence identity with SEQ ID NO:4.

8. The method according to claim 1, wherein at least 2% of soluble protein in the duckweed plant or duckweed plant cell or nodule is stable plasminogen.

9. The method according to claim 8, wherein at least 3% of soluble protein in the duckweed plant or duckweed plant cell or nodule is stable plasminogen.

10. The method according to claim 9, wherein at least 4% of soluble protein in the duckweed plant or duckweed plant cell or nodule is stable plasminogen.

11. A method for producing high levels of stable plasminogen in duckweed, wherein the method comprises the steps of: (a) culturing a duckweed plant or duckweed plant cell or nodule, wherein the duckweed plant or duckweed plant cell or nodule is stably transformed with a nucleic acid molecule comprising a nucleotide sequence encoding plasminogen, wherein the nucleotide sequence is SEQ ID NO:3; and (b) collecting stable plasminogen from the duckweed plant or duckweed plant cell or nodule.

12. The method of claim 11, wherein said nucleic acid molecule comprises at least one attribute selected from the group consisting of: (a) an operably linked nucleotide sequence comprising a plant intron that is inserted upstream of the nucleotide sequence encoding plasminogen; and (b) an operably linked nucleotide sequence comprising a translation leader sequence.

13. A method for producing high levels of stable plasminogen in duckweed, wherein said method comprises the steps of: (a) culturing a duckweed plant or duckweed plant cell or nodule, wherein said duckweed plant or duckweed plant cell or nodule is stably transformed with a nucleic acid molecule comprising a nucleotide sequence encoding plasminogen, said plasminogen having at least 95% sequence identity with SEQ ID NO:4, wherein said nucleic acid molecule comprises: 1) duckweed-preferred codons in the coding sequence for said plasminogen; 2) an operably linked nucleotide sequence comprising a plant intron that is inserted upstream of the coding sequence for said plasminogen, wherein said plant intron is SEQ ID NO:1; and 3) an operably linked nucleotide sequence comprising a translation leader sequence, wherein said translation leader sequence is SEQ ID NO:2; and (b) collecting said stable plasminogen from said duckweed plant or duckweed plant cell or nodule.

14. The method according to claim 1, wherein said signal peptide is a rice alpha-amylase signal peptide.

15. The method according to claim 14, wherein said signal peptide comprises SEQ ID NO:8.

16. The method according to claim 15, wherein said signal peptide is encoded by a nucleotide sequence comprising SEQ ID NO:7.

Details for Patent 7,659,445

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2024-02-11
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2024-02-11
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2024-02-11
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.